KEGG2 icon

KEGG Cancer

» Japanese
Cancer Cancer Mapping Pathogen Pathogen Checker

KEGG Cancer Resource

KEGG Cancer is an interface to various types of cancer information in KEGG, including KEGG PATHWAY, KEGG BRITE, KEGG DISEASE, KEGG DRUG, KEGG COMPOUND, and KEGG GLYCAN databases, as summarized below. It also contains cancer pathway mapping tools for understanding cancer genomes.

Cancer pathway maps
05200
Pathways in cancer
05230
Central carbon metabolism in cancer
05231
Choline metabolism in cancer
05202
Transcriptional misregulation in cancer
05206
MicroRNAs in cancer
05205
Proteoglycans in cancer
05204
Chemical carcinogenesis
05203
Viral carcinogenesis
05210
Colorectal cancer
05212
Pancreatic cancer
05214
Glioma
05216
Thyroid cancer
05221
Acute myeloid leukemia
05220
Chronic myeloid leukemia
05217
Basal cell carcinoma
05218
Melanoma
05211
Renal cell carcinoma
05219
Bladder cancer
05215
Prostate cancer
05213
Endometrial cancer
05222
Small cell lung cancer
05223
Non-small cell lung cancer
01521
EGFR tyrosine kinase inhibitor resistance
01524
Platinum drug resistance
DISEASE entries for cancers
H01513
Retinoblastoma
H00042
Glioma
H00043
Neuroblastoma
H01556
Meningioma
H00017
Esophageal cancer
H00018
Gastric cancer
H00034
Carcinoid
H00020
Colorectal cancer
H00044
Cancer of the anal canal
H00048
Hepatocellular carcinoma
H01557
Hepatic angiosarcoma
H00047
Gallbladder cancer
H00046
Cholangiocarcinoma
H00019
Pancreatic cancer
H01591
Gastrotintestinal stromal tumor
H00003
Acute myeloid leukemia (AML)
H00001
Acute lymphoblastic leukemia (ALL) (Precursor B lymphoblastic leukemia/lymphoma)
H00002
Acute lymphoblastic leukemia (ALL) (Precursor T lymphoblastic leukemia/lymphoma)
H00004
Chronic myeloid leukemia (CML)
H01590
Chronic eosinophilic leukemia
H01599
Hypereosinophilic syndrome
H00005
Chronic lymphocytic leukemia (CLL)
H00007
Hodgkin lymphoma
H00006
Hairy-cell leukemia
H01464
Mantle cell lymphoma
H00008
Burkitt lymphoma
H00009
Adult T-cell leukemia
H01463
Mycosis fungoides
H01601
Anaplastic large-cell lymphoma
H01512
Langerhans cell histiocytosis
H01511
Mast cell leukemia
H00010
Multiple myeloma
H00011
Lymphoplasmacytic lymphoma
H01613
Follicular lymphoma
H00012
Polycythemia vera
H01612
Essential thrombocytosis
H01605
Myelofibrosis
H00031
Breast cancer
H00027
Ovarian cancer
H01554
Fallopian tube cancer
H00028
Choriocarcinoma
H00026
Endometrial cancer
H00030
Cervical cancer
H00029
Vulvar cancer
H00049
Myxoid liposarcoma
H00037
Alveolar rhabdomyosarcoma
H00041
Kaposi's sarcoma
H00050
Synovial sarcoma
H00051
Alveolar soft part sarcoma
H00052
Clear cell sarcoma of soft tissue
H00053
Extraskeletal myxoid chondrosarcoma
H00036
Osteosarcoma
H00035
Ewing's sarcoma
H00039
Basal cell carcinoma
H00040
Squamous cell carcinoma
H00038
Malignant melanoma
H01463
Mycosis fungoides
H01555
Merkel cell carcinoma
H00021
Renal cell carcinoma
H00022
Bladder cancer
H00024
Prostate cancer
H00023
Testicular cancer
H00025
Penile cancer
H00032
Thyroid cancer
H01592
Medullary thyroid cancer
H01558
Parathyroid carcinoma
H00033
Adrenal carcinoma
H01510
Malignant paraganglioma
H00045
Pancreatic neuroendocrine tumor
H00247
Multiple endocrine neoplasia syndrome (MEN)
H00054
Nasopharyngeal cancer
H00055
Laryngeal cancer
H00016
Oral cancer
H01559
Oropharyngeal cancer
H01508
Salivary gland cancer
H01509
Tonsillar cancer
H00014
Non-small cell lung cancer
H00013
Small cell lung cancer
H00015
Malignant pleural mesothelioma
Cancer drugs
08340
Antineoplastics
07040
Antineoplastics - alkylating agents
07041
Antineoplastics - antimetabolic agents
07042
Antineoplastics - agents from natural products
07043
Antineoplastics - hormones
07045
Antineoplastics - protein kinases inhibitors
Cancer markers
08341
Pharmacogenomic biomarkers in FDA drug labels
08442
Tumor markers
Carcinogens
08008
Carcinogens
08006
Endocrine disrupting compounds
08007
Pesticides

Last updated: July 24, 2016
[ DISEASE | DRUG | MEDICUS | KEGG ]